Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Abstract: A new dioxime ligand and its copper(II), nickel(II), cobalt(II) were synthesized and
characterized by spectral methods. Elemental analyses and spectroscopic data of the ligands
and its copper (II), nickel(II) and cobalt(II) complexes are consistent with the formation of the
ligand and its metal complexes. In addition to the free ligand and copper(II), nickel(II) and
cobalt(II) complexes (3-6) were evaluated for biochemical properties
INTRODUCTION
The dioximes are the most widely used ligands in the coordination chemistry. [1-4] They
are now being as widely used mono-, di-, and poly nuclear transition metal complexes. This
ligand groups and their metal complexes play a key role of the coordination chemistry.
[5-8]
There is considerable interest in the chemistry of transition metal complexes due to the
biochemical activity and industrial uses.
[9,10]
and stimulated much interest for their noteworthy contributions in single molecule-based
magnetism,
hydrolysis.
[11]
[12]
This is due to the fact that dioximes offer opportunities for tuning the metal
[13]
carrying a radionuclide into a target cell, [14] in magnetic resonance imaging reagents. [15, 16] The
coordination number usually varies from four to six depending upon the donor site geometry
around the metal and above all the steric constraints imposed by the ligand itself.
This article describes the synthesis and characterization of a new oxime ligand and its
copper(II), nickel(II) and cobalt(II) complexes. The properties of the complexes were
investigated by magnetic, physical, and spectral methods. Furthermore, the free ligand and
copper(II), nickel(II) and cobalt(II) complexes (4-6) were evaluated for biochemical
properties
EXPERIMENTAL
General
1
H-NMR and 13C-NMR spectra were recorded on a Varian Gemini 200 spectrometer
with CDCl3 and DMSO-d6 as solvents. Chemical shifts () are reported in ppm relative to
tetramethylsilane using the solvent signal as internal reference. Elemental analyses (C, H, and
N) were performed on a Costech 4010 CHNS Elemental analyzer and metal contents were
estimated spectrophotometrically.
[17]
Matson 1000 Model FTIR spectrophotometer and UV-Vis spectra on an ATI Unicam UV2
Model UV-Vis spectrophotometer. Mass spectra (ESI) were recorded on a Micromass Quanto
LC-MS/MS spectrophotometer. All chemicals were of the highest quality available, obtained
from local suppliers, and used as received. The test microorganisms; E. coli RSKK 340, S.
aureus RSKK 96090, A. niger Z10, T. harzianum, (Rifai) were obtained from the Refik
Saydam National Public Health Agency-Turkey.
(3E,8E)-3,9-dimethyl-6,6-diphenyl-5,7-dioxa-4,8-diazaundeca-3,8-diene-2,10-dione, (2)
A solution
of
2,3-butanedione
monoxime
(2.1
g,
20
mmol)
and
1,1'-
Antimicrobial Activity
The free ligand and its metal complexes, the metal salts, and the control (DMSO ) was
tested in vitro against gram-positive bacteria (Staphylococcus aureus), and gram-negative
bacteria (Escherichia coli) by paper disc method.
[18]
(0.5 and 1 mgL1) in different concentrations DMSO. The results were compared with
ciprofloxin. [19]
The cultures of fungi were purified by single-spore isolation technique. The glucose
nitrate (GN) medium was used for growth of fungi. The mycelia biomass was then dried along
with filter paper in an oven at 655 oC to constant weight, cooled, and finally weighed. The
MDW was obtained by subtracting the weight of mycelium-free filter paper from final dry
weight.
[20]
The percentage error was found to be 0.01. The percent decrease in MDW to the
test compound in each case was calculated and tabulated in terms of average percentage
inhibition. The results indicate that the free ligand and its Cu (II), Ni (II), and Co (II)
complexes arrested the growth of fungi.
RESULS AND DISCUSSION
A new dioxime was synthesized and characterized by elemental analysis, 1H-NMR,
13
C-NMR, IR and mass spectral data (Scheme 1). Then the metal complexes of a new ligands
have been prepared and characterized by elemental analysis, magnetic moment, Uv-Vis, and
mass spectral data. In the proposed structure of this ligand N4 donor units available for the
complexation of transition metal ions.
NMR Spectra
The 1H-NMR spectra data were given in the experimental section. In the proton NMR
spectrum of the dioxime (DPTMD) was seen at 1.85 singlet (6H, -CH 3); at 2.19 singlet (6H,
-CH3); at 7.25-7.54 multiplet (10H, -C6H5-) at 9.0 br. singlet (2H, C=NOH) (in CDCl3). The
eleven resonance signals were observed in the 13C-NMR spectra of dioxime ligand, which was
also consistent with the formula for the dioxime ligand (DPTMD) (Scheme 1). The signals
have been seen in the singlet at = 9.0 ppm for the =N-OH hydrogen, disappears on
deuterium exchange.
Mass Spectra
The mass spectra of the dioxime and its Cu(II), Ni(II), and Co(II) complexes were
recorded in DMSO solution. In the mass spectra (ESI) was seen the molecular ion at m/z =
396.25 M+ for the free ligans (DPTMD). This result were indicated formation of ligands. The
molecular ion peaks appeared (m/z, ESI) at 459.4[M+1]+, 453.5 and 525.32 [M+] for the CuDPTMD, Ni-DPTMD and Co-DPTMD respectively. The mass spectra showed the formation
of the ligand and its metal complexes.
IR Spectra
Characteristic IR bands of the free ligand and its metal complexes(in cm -1) were given
in Table 1. In general, metal complexes also suggest that a similar structure, exhibits very
comparable IR bands. The strong band at 3240 and 1588 cm -1 might be assigned to (O-H)
and (C=N) vibration for the dioxime ligand (DPTMD) respectively.
[2, 21]
formation (4-6) the vibrational bands were shifted to a higher and lower frequency ca. 10-40
cm-1. In the IR spectrum of free ligand was observed at 3240 cm -1 OH vibrational band but
could not be observed in the metal complexes. Instead, a weak vibration band is observed ca.
at 1700 cm-1, and this is due to O-H.O bridge.
[1, 3]
complexation support the concept of coordination of ligand the dioxime ligand (DPTMD)
C=N nitrogen atoms (Fig 1).
Table 2 and 3. The band around ca. at 320-420 nm was due to the n * transition of the
nonbonding electron present on the nitrogen or oxygen atom of the ligand. The band around
ca. at 260-300 nm was due to the * transition. In the complexes (4-6), d-d transitions
were observed at ca. 525570 nm (Table 2). The energy of the d-d transition suggested a
distorted square planar geometry. [2, 22]
Electronic spectral data of the copper complex coupled with detected magnetic
moment ca. 1.77 B.M. suggest octahedral geometry.
[23, 24]
with magnetic moment ca. 2.80 B.M. suggest octahedral or square planar geometry for Ni(II)
complex. [24, 25] The magnetic moment of cobalt(II) complex ca. 3.90 B.M (Table 3) indicate a
high-spin square planar complex.
[25, 26]
Antimicrobial Activity
The oxime ligand and its metal complexes were tested to antimicrobial activity against one
gram-positive bacterium (S. Aureus), gram-negative bacterium (Escherichia coli), and fungi
A. Niger and Trichoderma. The free ligand and its metal complexes exhibit antibacterial
activity against both strains. Cu (II), Ni (II), and Co (II) complexes exhibit higher activity
than the free ligand. The ciprofloxin was chosen as the standard for comparison antibacterial
inhibitions. The free ligand and its metal complexes showed lower activity than standard (table
4). The metal salts did not show antimicrobial activity. [27, 28] While biological activity does not
show metal salts, metal complexes show activity is consistent with the literature.
[29]
The
antibacterial inhibition of metal complexes has been found to concentration dependent and
was found to increase with increasing concentration. The Cu (II) complex exhibits higher
activity against each class of organism. The literature supports to the nature of this case.
[30]
The free ligand and its metal complexes show more activity against gramnegative E. Coli
than against gram-positive S. Aureus. The metal complex biological activities follow the order
CuL >CoL >NiL, which is exactly same as the order of stability constants of these
complexes. The Cu (II) complex is more active than the free ligand against A. Niger, but free
ligand is more active against Trichoderma.
CONCLUSIONS
In this study, a new dioxime ligand and its copper(II), nickel(II), cobalt(II) were synthesized
and characterized by spectral methods. Elemental analyses and spectroscopic data of the
ligands and its copper (II), nickel(II) and cobalt(II) complexes are consistent with the
formation of the ligand and its metal complexes. In addition to the free ligand and metal
complexes were evaluated for biochemical properties. The all metal complexes were found to
be paramagnetic. The metal ions were complexed with nitrogen atoms(N 4) of dioxime ligand.
The environment of metal ions was proposed as distorted tetragonal geometry.
Acknowledgement
This work was supported by Karadeniz Technical University Research Fund, and its project
code is 2005,111.02.2.
TABLE 1
Characteristic IR bands of the free ligand(DPTMD) and its metal complexes (in cm-1)
Compound
DPTMD
Cu-DPTMD
Ni-DPTMD
Co-DPTMD
(-O-H)
3240
3225
3207
3215
(O-HN)
1800
1790
1795
(C=N)
1588
1596
1570
-
TABLE 2
Electronic spectral data for the ligands and its metal complexes, (max in nm)
Compound
n
d-d band
DPTMD
270
310
Cu-DPTMD
272
420
570
Ni-DPTMD
275
380
540
Co-DPTMD
270
365
525
a
b
Per metal atom at 297 K(B.M.). UV/Vis spectra were taken in DMF.
TABLE 3
Physical data of the ligands and its metal complexes.
Comp.
Empirical formula
Color
Yield
MS(m/z)
aef
DPTMD
C21H24N4O4
white
63
396
Cu-DPTMD C21H24CuN2O4Cl
blue
55
529
1.77
Ni-DPTMD C21H24NiN4O4Cl
red
60
524
2.80
Co-DPTMD C21H24CoN4O4Cl
brown
70
525
3.90
TABLE 4
Antibacterial activities and antifungal activity weight (mg) (% inhibition) of the oxime ligand
and its metal complexes
Antibacterial activity (mg mL1)
E. coli
S. Aureus
Conc.
0.5
0.5
0.5
0.5
Control(DMSO)
Ciprofloxin
40
45
42
44
74
72
65
60
DPTMD
12
12
11
18
75(20)
70(25)
50(20)
30(60)
Cu-DPTMD
20
28
15
26
65(35)
40(60)
35(50)
25(75)
Ni-DPTMD
15
22
12
20
60(40)
25(75)
35(65)
30(60)
Co-DPTMD
12
20
12
15
55(25)
30(70)
30(60)
25(65)
REFERENCES
1. Karabocek, S.; Bayraktar, U.; Karabocek, N.; Sahin, Z.S.; Isik, S.; Muhsir, S. J. Coord.
Chem. 2012, 65, 1118-1129.
2. Karabocek, N.; Armutcu, M.; Karabocek, S.; Tanak, H.; Isik, S.; Baskan, O. Synth. React.
Inorg. Met.-Org. Nano-Met. Chem. 2011, 41, 1249-1256.
3. Karabocek, N:; Kucukdumlu, A.; Senses, E.; Karabocek, S.; Ozcimder, R. Synth. React.
Inorg. Met.-Org. Nano-Met. Chem. 2011, 41, 1095-1101.
4. Karabocek, S.; Karabocek, N.; Armutcu, A. Transition Met. Chem. 2006, 31, 459-464
5. Celik, C.; Tumer, M.; Serin, S. Synth. React. Inorg. Met.-Org. Chem. 2002, 32, 1839-1854.
6. Rasool, R.; Hasnain, S.; Nishat, N.;Desig. Monom. Poly. 2014,17, 217-226.
7. Elbohy, S.A.H.; Int. J. Electrochem. Science2013, 8, 12387-12401.
8. Sumrra, Sajjad H.;Chohan, Zahid H.J. Enz.Inhibit. Med. Chem. 2013, 28, 1291-1299.
9. Ramesh, R.; Sivagamasundari, M. Synth. React. Inorg. Met.-Org. Chem. 2003, 33, 899910.
10. Maurya, R.C.; Verma, R.; Singh, T. Synth. React. Inorg. Met.-Org. Chem. 2003, 33, 309325.
11. Rodriquez de Barbarin, C.O.; Bailey, N.A.; Fenton, D.E.; He, Q.Y. J. Chem. Soc., Dalton
Trans.
1997, 161-166.
12. Khan, M.M.T.; Halligudi S.B.; Shukla, S.; Shaikh, Z.A. J. Mol. Catal.1990, 57, 301-305.
13. Kimura, E.; Kodama, Y.; Koike, T.; Shiro, M. J. Am. Chem. Soc.,1995, 117, 8304-8311.
14. Parker, D. Chem. Soc. Rev.,1990, 19, 271-291.
15. Dischino, D.D.; Delaney, E.J.;Emswiler, J.E.;Gaughan, G.T.; Prasad, J.S.; Srivastava,
S.K.; TweedleM.F. Inorg. Chem., 1991, 30, 1265-1269.
16. Fenton, D.E. Chem. Soc. Rev. 1999, 28, 159-168.
17. Vogel, A.I. Textbook of Quantitative Inorganic Analysis, fourth ed, Longman,
London, UK, 1978.
18. Munde, A.S.; Jagdale, A.N.; Jadhav, S.M.; Chondhekar, T.K. J. Kor. Chem. Soc., 2009,
53, 407-414.
19. Ahmad, I.; Mehmood, Z.; Mohammed, F. J. Ethnopharmacol., 1998, 62, 183-193.
20. Woods, G.L.; Brown-Elliott, B.A.; Desmond, E.P.; Hall, G.S.; Heifets, L.; Pfyffer, G.E.;
Ridderhof, J.C.; Wallace, R.J.; Warren, N.C.; Witebsky, F.G. Approved Standard. NCCLS
document M24-A, 2003.
21. Karabocek, S.; Bayraktar, U.; Karabocek, N.;Sahin, Z. S.;Isik, S.; Muhsir, S.J. Coord.
Chem.2012, 65, 1118-1129.
22. Mashaly, M.M.; Abd-Elwahab, Z.H.; Faheim, A.A. Synth. React. Inorg. Met.-Org. Chem.
2004, 34, 233-268.
23. Canbolat, E.; Yazci, A.; Kaya, M. J. Coord. Chem. 2007, 60, 473-480.
24. Eichhorn, G.L.; Bailar, J.C. J. Am. Chem. Soc. 1953, 75, 2905-2907.
25. Lever, A.B.P. Inorganic Electronic Spectroscopy; Elsevier: Amsterdam, 1968, pp. 275361.
26. Cotton, F.A.; Wilkinson, G. Advenced Inorganic Chemistry, 5thed.; Willey: new York,
1988.
27. Efthimiadou, B.K.; Psomas, G.; Sankis, Y.; Katsaros, N. J. Inorg. Biochem., 2007, 101,
525-535.
28. El-Dissouky, A.; Al-Fulaji, O.; Awad, M.K.; Rizk, S. J. Coord. Chem., 2010, 63, 330-345.
29. Thangadurai, T.D.; Natarajan, K. Synth. React. Inorg. Met.-Org. Nano-Met. Chem., 2001,
31, 549-567.
30. Raman, N.; Johnson Raja, S.; Sakthivel, A. J. Coord. Chem., 2009, 62, 691-709.
KOH
Cl
+ 2 HON
O
NH2OH.HCl
EtOH/H2O
Cl
(1)
(2)
Figure legends
FIG.1. Proposed structure of the metal complexes
FIG. 2. The 1H-NMR spectra of DPTMD (in CDCl3)
FIG. 3. Mass spectra of DPTMD
N OH
N OH
Py
(3)
N O
M
H Cl
N O